

In the Top 5% of 1339 Similar Sized Companies on Comparably
1st place versus 5 competitors rated on Comparably
Kevin A. Lobo has been CEO of Stryker since October 1, 2012, and also assumed the role of Chairman of the Board on July 22, 2014. Mr. Lobo joined Stryker in 2011 and had previously been Group President of Orthopaedics.
Mr. Lobo is the chairman of the Advanced Medical Technology Association (AdvaMed) Board of Directors and serves on the Board of Directors for Parker Hannifin Corporation, the global leader in motion and control technologies. He is also a member of the Business Roundtable and Business Council and serves on some community boards.
Mr. Lobo has a broad business career that includes executive positions in general management and finance. After holding finance positions with KPMG, Unilever and Kraft Canada he spent eight years with Rhone-Poulenc, including roles based in Europeas Corporate Controller of Rhodia, the chemical spin-out, and General Manager of Specialty Phosphates EMEA. He then spent eight years at Johnson & Johnson, including President J&J Medical Canada and President of Ethicon Endo Surgery.
The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Stryker.
Based on 318 ratings, Kevin Lobo ranks right above Johnson & Johnson's CEO, Joaquin Duato.
Stryker's CEO is highly regarded by the IT department, the Marketing department, and the Communications department. However, employees who have been at the company 1 to 2 Years, the Finance department, and the Customer Support department have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.
Stryker ranks in the Top 5% of other companies on Comparably with 10,000+ Employees for CEO Rating Score.
